Active, not recruitingPhase 2NCT04160546

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundacion CRIS de Investigación para Vencer el Cáncer
Principal Investigator
Joaquín Martínez López, MD
Hospital Universitario 12 de Octubre
Intervention
Ponatinib 15 MG(drug)
Enrollment
80 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2025

Study locations (13)

Collaborators

Incyte Biosciences UK · Apices Soluciones S.L.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04160546 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease →

← Back to all trials